Ad is loading...
NVYTF
Price
$0.66
Change
-$0.00 (-0.00%)
Updated
Nov 8 closing price
ODYY
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
Ad is loading...

NVYTF vs ODYY

Header iconNVYTF vs ODYY Comparison
Open Charts NVYTF vs ODYYBanner chart's image
Novacyt Clamart
Price$0.66
Change-$0.00 (-0.00%)
Volume$245
CapitalizationN/A
Odyssey Group
Price$0.02
Change-$0.00 (-0.00%)
Volume$35K
CapitalizationN/A
NVYTF vs ODYY Comparison Chart
Loading...
View a ticker or compare two or three
VS
NVYTF vs. ODYY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVYTF is a Hold and ODYY is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (NVYTF: $0.66 vs. ODYY: $0.02)
Brand notoriety: NVYTF and ODYY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVYTF: 41% vs. ODYY: 113%
Market capitalization -- NVYTF: $56.79M vs. ODYY: $10.98M
NVYTF [@Medical Specialties] is valued at $56.79M. ODYY’s [@Medical Specialties] market capitalization is $10.98M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVYTF’s FA Score shows that 0 FA rating(s) are green whileODYY’s FA Score has 2 green FA rating(s).

  • NVYTF’s FA Score: 0 green, 5 red.
  • ODYY’s FA Score: 2 green, 3 red.
According to our system of comparison, ODYY is a better buy in the long-term than NVYTF.

Price Growth

NVYTF (@Medical Specialties) experienced а 0.00% price change this week, while ODYY (@Medical Specialties) price change was -15.79% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
NVYTF($56.8M) has a higher market cap than ODYY($11M). NVYTF YTD gains are higher at: -11.374 vs. ODYY (-84.000). NVYTF has higher annual earnings (EBITDA): -1.71M vs. ODYY (-6.48M). NVYTF has more cash in the bank: 102M vs. ODYY (1.23K). NVYTF (1.87M) and ODYY (1.9M) have identical debt. NVYTF has higher revenues than ODYY: NVYTF (95.8M) vs ODYY (0).
NVYTFODYYNVYTF / ODYY
Capitalization56.8M11M516%
EBITDA-1.71M-6.48M26%
Gain YTD-11.374-84.00014%
P/E Ratio1.33N/A-
Revenue95.8M0-
Total Cash102M1.23K8,265,802%
Total Debt1.87M1.9M98%
FUNDAMENTALS RATINGS
ODYY: Fundamental Ratings
ODYY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
7
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COF185.142.14
+1.17%
Capital One Financial
NEXT7.26-0.01
-0.14%
NextDecade Corp
GROW2.39N/A
-0.21%
US Global Investors
MSB25.51-0.30
-1.16%
Mesabi Trust
IONS34.34-2.89
-7.76%
Ionis Pharmaceuticals

NVYTF and

Correlation & Price change

A.I.dvisor tells us that NVYTF and ARAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVYTF and ARAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVYTF
1D Price
Change %
NVYTF100%
N/A
ARAY - NVYTF
31%
Poorly correlated
-2.30%
MBGNF - NVYTF
28%
Poorly correlated
N/A
PRCT - NVYTF
21%
Poorly correlated
+3.53%
NUMD - NVYTF
10%
Poorly correlated
-5.37%
ODYY - NVYTF
8%
Poorly correlated
-13.51%
More

ODYY and

Correlation & Price change

A.I.dvisor tells us that ODYY and NHNKY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ODYY and NHNKY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ODYY
1D Price
Change %
ODYY100%
-13.51%
NHNKY - ODYY
27%
Poorly correlated
-7.94%
ZTEK - ODYY
22%
Poorly correlated
+29.96%
OCPNF - ODYY
9%
Poorly correlated
-1.49%
NVYTF - ODYY
8%
Poorly correlated
N/A
PFGTF - ODYY
5%
Poorly correlated
N/A
More